Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the firm’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $143,704,885.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
J.H. Whitney Equity Partners V also recently made the following trade(s):
- On Friday, August 21st, J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00.
- On Tuesday, June 30th, J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.01, for a total value of $19,376,470.35.
- On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.00, for a total value of $7,355,112.00.
- On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total value of $36,455,577.60.
Aveanna Healthcare Stock Performance
Shares of NASDAQ AVAH opened at $13.62 on Thursday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The company has a market capitalization of $2.97 billion, a P/E ratio of 11.07, a P/E/G ratio of 0.85 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 12 month low of $5.93 and a 12 month high of $13.98. The stock has a 50 day moving average of $9.95 and a 200-day moving average of $8.03.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. Truist Financial increased their price objective on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research report on Monday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. BMO Capital Markets upped their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Raymond James Financial raised their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Finally, Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $10.00 to $11.00 in a report on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $12.89.
View Our Latest Research Report on AVAH
Institutional Investors Weigh In On Aveanna Healthcare
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Dynamic Technology Lab Private Ltd boosted its position in shares of Aveanna Healthcare by 8.9% during the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after acquiring an additional 1,151 shares in the last quarter. Barclays PLC raised its position in Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after purchasing an additional 1,366 shares in the last quarter. Franklin Resources Inc. raised its position in Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after purchasing an additional 1,528 shares in the last quarter. Intech Investment Management LLC lifted its stake in Aveanna Healthcare by 9.8% during the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after purchasing an additional 1,739 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Recommended Stories
- Five stocks we like better than Aveanna Healthcare
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
